Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_assertion type Assertion NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_head.
- NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_provenance.
- NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_assertion evidence source_evidence_literature NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_provenance.
- NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_assertion SIO_000772 25150872 NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_provenance.
- NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_assertion wasDerivedFrom befree-2016 NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_provenance.
- NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_assertion wasGeneratedBy ECO_0000203 NP1213136.RAAO_fyzQKSeRvKMYKDmF_k8ZBFmSDnM3DIMjwOXUllrI130_provenance.